Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion type Assertion NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_head.
- NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion description "[These observations suggest that icotinib-induced upregulation of Cbl-b is responsible, at least in part, for the antitumor effect of icotinib via the inhibition of phosphoinositide 3-kinase (PI3K)/Akt and mitogen-activated protein kinase pathways in EGFR-mutated NSCLC cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_provenance.
- NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion evidence source_evidence_literature NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_provenance.
- NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion SIO_000772 23586056 NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_provenance.
- NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion wasDerivedFrom befree-2016 NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_provenance.
- NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_assertion wasGeneratedBy ECO_0000203 NP1069304.RA50V0ox2ff7keQm4VKpmocEOH84B1ogU5eEG98g-pyJ0130_provenance.